Beckman Coulter, a global leader in the clinical diagnostics industry has announced that it is joining forces with Sepsis Alliance to support the Sepsis Coordinator Network. The Sepsis Coordinator Network (SCN), the first of its kind, is a community created by Sepsis Alliance to provide sepsis best practice resources and guidance to sepsis coordinators and all health professionals across the country. This peer-to-peer association for healthcare professionals is committed to helping save lives by improving patient outcomes. Sepsis is the body's life-threatening reaction to infection and the leading cause of death in hospitals in the United States, taking a life every two minutes. This year, Beckman Coulter received FDA clearance and CE mark for its Early Sepsis Indicator, a hematology-based solution designed to alert emergency department clinicians to the possibility of sepsis or risk of developing sepsis.
Sepsis is a serious organ dysfunction that can also lead to septic shock, which is a medical emergency. According to Healthline, low birth weight and premature babies are more susceptible to late onset sepsis because their immune systems are immature.
The SCN is led by a team of expert leaders in the field of nursing with critical experience in caring for sepsis patients, and developing and implementing sepsis protocols. It provides its members with evidence-based, best-practice resources and guidance to identify and treat sepsis. Since its launch on May 22, 2018, the network has grown to include more than 1,300 healthcare professionals from over 1,000 hospitals in all 50 states, covering more than 390,000 hospital beds.
According to Peter Soltani, Ph.D., Senior Vice President and General Manager of Beckman Coulter's hematology business, "Delayed treatment of sepsis can cause cardiovascular collapse, tissue damage, organ failure and ultimately, death. The availability of timely, accurate detection solutions is critical to stopping the progression of this deadly condition. Having recently launched our Early Sepsis Indicator, we are happy to join the Sepsis Coordinator Network in the fight against this life-threatening disease."
Thomas Heymann, President and Executive Director of Sepsis Alliance expressed their gratitude and appreciation of Beckman Coulter, remarking that the rapid and truly impressive membership growth of the Sepsis Coordinator Network would not have been possible without the support of companies like Beckman Coulter.
This partnership is in keeping with Beckman Coulter's commitment to continuous improvement of efficiency and clinical outcomes, quality patient care, and improved healthcare.